Find Alectinib Hydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

133 RELATED EXCIPIENT COMPANIES

214EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1256589-74-8, Af-802 hydrochloride, Alectinib hcl, Alecensa, P9yy73lo6j, Alectinib hydrochloride (jan)
Molecular Formula
C30H35ClN4O2
Molecular Weight
519.1  g/mol
InChI Key
GYABBVHSRIHYJR-UHFFFAOYSA-N
FDA UNII
P9YY73LO6J

Alectinib Hydrochloride
1 2D Structure

Alectinib Hydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile;hydrochloride
2.1.2 InChI
InChI=1S/C30H34N4O2.ClH/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29;/h5-6,15-17,21,32H,4,7-14H2,1-3H3;1H
2.1.3 InChI Key
GYABBVHSRIHYJR-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C.Cl
2.2 Other Identifiers
2.2.1 UNII
P9YY73LO6J
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Alecensa

2. Alectinib

3. Ch5424802

4. Ro5424802

2.3.2 Depositor-Supplied Synonyms

1. 1256589-74-8

2. Af-802 Hydrochloride

3. Alectinib Hcl

4. Alecensa

5. P9yy73lo6j

6. Alectinib Hydrochloride (jan)

7. Alectinib (hydrochloride)

8. Ch5424802 (hydrochloride)

9. Schembl14991271

10. 5h-benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-, Hydrochloride (1:1)

11. Alectinib Hydrochloride [jan]

12. 9-ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5h-benzo[b]carbazole-3-carbonitrile Hydrochloride

13. Unii-p9yy73lo6j

14. Alecensa (tn)

15. 5h-benzo(b)carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-, Hydrochloride (1:1)

16. Alectinib Monohydrochloride

17. Af-802 (hydrochloride)

18. Agn-pc-09o9bf

19. Ro5424802 (hydrochloride)

20. Chembl3707320

21. Chebi:62268

22. Ch5424802 Hcl

23. Dtxsid10154841

24. Ch 5424802, Alectinib Hcl

25. Bcp09075

26. Ex-a1553

27. Alectinib Hydrochloride [mi]

28. Ch-5424802 Hydrochloride

29. Hy-13011a

30. Mfcd27987893

31. S5232

32. Ccg-264759

33. Cs-3480

34. Sb16516

35. Alectinib Hydrochloride [who-dd]

36. 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5h-benzo[b]carbazole-3-carbonitrile,hydrochloride

37. Ac-29721

38. As-17062

39. Alectinib Hydrochloride [orange Book]

40. D10450

41. Q27104897

42. Ch5424802 Hcl Salt, Alectinib Hcl Salt, Af802 Hcl Salt

43. Ch-5428402 Hcl; Af-802 Hydrochloride; Rg-7853 Hydrochloride; Ro-5424802 Hydrochloride

44. 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5h-benzo[b]carbazole-3-carbonitrile Hydrochloride (1:1)

45. 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5h-benzo[b]carbazole-3-carbonitrile Monohydrochloride Salt

46. 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5h-benzo[b]carbazole-3-carbonitrile;hydrochloride

47. Alectinib Hydrochloride;af-802 Hydrochloride;ch-5424802 Hydrochloride;rg-7853 Hydrochloride;ro-5424802 Hydrochloride

2.3.3 Other Synonyms

1. Alectinib

2. 1256580-46-7

3. Arq-761

4. Cas 1416163-60-4

5. Cas 1256580-46-7

2.4 Create Date
2011-07-05
3 Chemical and Physical Properties
Molecular Weight 519.1 g/mol
Molecular Formula C30H35ClN4O2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count3
Exact Mass518.2448541 g/mol
Monoisotopic Mass518.2448541 g/mol
Topological Polar Surface Area72.4 Ų
Heavy Atom Count37
Formal Charge0
Complexity867
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

Alecensa as monotherapy is indicated for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).

Alecensa as monotherapy is indicated for the treatment of adult patients with ALKpositive advanced NSCLC previously treated with crizotinib.


5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Kinase Inhibitors [MoA]; Kinase Inhibitor [EPC]
5.2 ATC Code

L01ED03


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

The Pharmacy Technology
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPorton Pharma Solutions: Value creation via innovation & discovery through technical platforms.

Flag China
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 40093

Submission : 2024-06-13

Status : Active

Type : II

Porton Company Banner

02

The Pharmacy Technology
Not Confirmed

02

The Pharmacy Technology
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 33869

Submission : 2019-06-12

Status : Inactive

Type : II

blank

03

Hetero Labs Ltd

India

USDMF

arrow
The Pharmacy Technology
Not Confirmed

03

The Pharmacy Technology
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 39383

Submission : 2024-01-30

Status : Active

Type : II

blank

04

The Pharmacy Technology
Not Confirmed

04

The Pharmacy Technology
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2019-07-19

Pay. Date : 2019-05-28

DMF Number : 33637

Submission : 2019-02-28

Status : Active

Type : II

blank

05

Natco Pharma Ltd

India

USDMF

arrow
The Pharmacy Technology
Not Confirmed

05

The Pharmacy Technology
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2022-06-28

Pay. Date : 2022-03-15

DMF Number : 36908

Submission : 2022-03-25

Status : Active

Type : II

blank

06

The Pharmacy Technology
Not Confirmed

06

The Pharmacy Technology
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 34128

Submission : 2019-12-16

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-more

01

Compamed
Not Confirmed
arrow
arrow
Compamed
Not Confirmed

Alectinib Hydrochloride IH

Date of Issue : 2022-09-30

Valid Till : 2025-09-15

Written Confirmation Number : WC-0115A3

Address of the Firm : D-35, Industrial Area, Kalyani, Dist Nadia-741 235, West Bengal 

blank

02

Compamed
Not Confirmed
arrow
arrow
Compamed
Not Confirmed

Alectinib Hydrochloride IHS

Date of Issue : 2022-09-02

Valid Till : 2025-05-05

Written Confirmation Number : WC-0349

Address of the Firm : MIs. MSN Laboratories Private Limited, Unit-II, sv. No, 50, Kardanur (Village), ...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1704997800,"product":"ALECTINIB HYDROCHLORIDE","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"ACTAVIS INC","customerCountry":"TAIWAN","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"10000","totalValueFC":"19817.5","currency":"USD","unitRateINR":823533,"date":"12-Jan-2024","totalValueINR":"1647066","totalValueInUsd":"19817.5","indian_port":"Hyderabad Air","hs_no":"29331999","bill_no":"6698466","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705948200,"product":"ALECTINIB HYDROCHLORIDE IH","address":"HETERO CORPORATE, NO. 7-2-A2,","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"HANDA PHARMACEUTICALS INC","customerCountry":"TAIWAN","quantity":"0.32","actualQuantity":"0.32","unit":"KGS","unitRateFc":"25600","totalValueFC":"7914","currency":"USD","unitRateINR":2055459.4375,"date":"23-Jan-2024","totalValueINR":"657747.02","totalValueInUsd":"7914","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"6945894","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2,, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712255400,"product":"ALECTINIB HYDROCHLORIDE IH","address":"HETERO CORPORATE, NO. 7-2-A2,","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"TO THE ORDER OF","customerCountry":"TAIWAN","quantity":"0.18","actualQuantity":"0.18","unit":"KGS","unitRateFc":"25600","totalValueFC":"4500.3","currency":"USD","unitRateINR":2087804.4444444445,"date":"05-Apr-2024","totalValueINR":"375804.8","totalValueInUsd":"4500.3","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"8914614","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2,, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719340200,"product":"ALECTINIB HYDROCHLORIDE IH","address":"HETERO CORPORATE, NO. 7-2-A2,","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"TO THE ORDER OF","customerCountry":"RUSSIA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"26666.7","totalValueFC":"7839.9","currency":"USD","unitRateINR":2181563.3333333335,"date":"26-Jun-2024","totalValueINR":"654469","totalValueInUsd":"7839.9","indian_port":"Hyderabad Air","hs_no":"29349990","bill_no":"1961909","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"HETERO CORPORATE, NO. 7-2-A2,, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724265000,"product":"ALECTINIB HYDROCHLORIDE","address":"MSN HOUSE, PLOT NO. C-24,","city":"HYDERABAD. AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"KUKJEON PHARMACEUTICAL CO","customerCountry":"REPUBLIC OF KOREA","quantity":"0.15","actualQuantity":"0.15","unit":"KGS","unitRateFc":"15000","totalValueFC":"2154","currency":"USD","unitRateINR":1204500,"date":"22-Aug-2024","totalValueINR":"180675","totalValueInUsd":"2154","indian_port":"Hyderabad Air","hs_no":"29331999","bill_no":"3409612","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"MSN HOUSE, PLOT NO. C-24,, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726252200,"product":"ALECTINIB HYDROCHLORIDE. BATCH NO. 104202-01-00003. MFG. 20.01.2024 RETEST 19.01.2026","address":"2ND FLOOR, CHINUBHAI CENTRE,","city":"AHMEDABAD, GUJARAT","supplier":"PORTON PHARMA SOLUTIONS","supplierCountry":"CHINA","foreign_port":"CHONGQING","customer":"INTAS PHARMACEUTICALS","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.025","unit":"KGS","unitRateFc":"11000","totalValueFC":"531.9","currency":"USD","unitRateINR":"1782900","date":"14-Sep-2024","totalValueINR":"44572.5","totalValueInUsd":"531.9","indian_port":"Ahmedabad Air","hs_no":"29333990","bill_no":"5604847","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"CHONGQING","supplierAddress":"1 Fine Chemical Zone, Chongqing Che mical Industry Park, Changshou,Chon gqing,401221 CHINA Chongqing, , CHI CHINA","customerAddress":"2ND FLOOR, CHINUBHAI CENTRE,"}]
12-Jan-2024
14-Sep-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

FDF Dossiers

read-more
read-more

01

F. Hoffmann-La Roche

Switzerland
Compamed
Not Confirmed
arrow

F. Hoffmann-La Roche

Switzerland
arrow
Compamed
Not Confirmed

ALECTINIB HYDROCHLORIDE

Brand Name : ALECENSA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 150MG BASE

Packaging :

Approval Date : 2015-12-11

Application Number : 208434

Regulatory Info : RX

Registration Country : USA

blank

02

F. Hoffmann-La Roche

Switzerland
Compamed
Not Confirmed
arrow

F. Hoffmann-La Roche

Switzerland
arrow
Compamed
Not Confirmed

Alectinibum

Brand Name : Alecensa

Dosage Form : Caps

Dosage Strength : 150mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

F. Hoffmann-La Roche

Switzerland
Compamed
Not Confirmed
arrow

F. Hoffmann-La Roche

Switzerland
arrow
Compamed
Not Confirmed

ALECTINIB (ALECTINIB HYDROCHLORIDE)

Brand Name : ALECENSARO

Dosage Form : CAPSULE

Dosage Strength : 150MG

Packaging : 240

Approval Date :

Application Number : 2458136

Regulatory Info : Prescription

Registration Country : Canada

blank

04

F. Hoffmann-La Roche

Switzerland
Compamed
Not Confirmed
arrow

F. Hoffmann-La Roche

Switzerland
arrow
Compamed
Not Confirmed

Alectinib

Brand Name : Alecensa

Dosage Form : CAPS

Dosage Strength : 150MG

Packaging : 224X1MG

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

05

F. Hoffmann-La Roche

Switzerland
Compamed
Not Confirmed
arrow

F. Hoffmann-La Roche

Switzerland
arrow
Compamed
Not Confirmed

alectinib

Brand Name : Alecensa

Dosage Form :

Dosage Strength :

Packaging : 224

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Taste Masking

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Empty Capsules

read-more
read-more

Vegetarian Capsules

read-more
read-more

Coloring Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

API Stability Enhancers

read-more
read-more

Emulsifying Agents

read-more
read-more

Parenteral

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Solubilizers

read-more
read-more

Topical

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
American Pharma Summit
Not Confirmed

HOFFMANN-LA ROCHE

Switzerland
arrow
American Pharma Summit
Not Confirmed

ALECTINIB HYDROCHLORIDE

US Patent Number : 9365514

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208434

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-04

blank

02

arrow
American Pharma Summit
Not Confirmed

HOFFMANN-LA ROCHE

Switzerland
arrow
American Pharma Summit
Not Confirmed

ALECTINIB HYDROCHLORIDE

US Patent Number : 9440922

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208434

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-06-09

blank

03

arrow
American Pharma Summit
Not Confirmed

HOFFMANN-LA ROCHE

Switzerland
arrow
American Pharma Summit
Not Confirmed

ALECTINIB HYDROCHLORIDE

US Patent Number : 9126931

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 208434

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-05-29

blank

04

arrow
American Pharma Summit
Not Confirmed

HOFFMANN-LA ROCHE

Switzerland
arrow
American Pharma Summit
Not Confirmed

ALECTINIB HYDROCHLORIDE

US Patent Number : 11433076

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208434

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-04-24

blank

05

arrow
American Pharma Summit
Not Confirmed

HOFFMANN-LA ROCHE

Switzerland
arrow
American Pharma Summit
Not Confirmed

ALECTINIB HYDROCHLORIDE

US Patent Number : 10350214

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208434

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-04-24

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

read-more
read-more

01

arrow
BioFlorida Conference
Not Confirmed

HOFFMANN-LA ROCHE

Switzerland
arrow
BioFlorida Conference
Not Confirmed

ALECTINIB HYDROCHLORIDE

Exclusivity Code : ODE-159

Exclusivity Expiration Date : 2024-11-06

Application Number : 208434

Product Number : 1

Exclusivity Details :

blank

02

arrow
BioFlorida Conference
Not Confirmed

HOFFMANN-LA ROCHE

Switzerland
arrow
BioFlorida Conference
Not Confirmed

ALECTINIB HYDROCHLORIDE

Exclusivity Code : I-947

Exclusivity Expiration Date : 2027-04-18

Application Number : 208434

Product Number : 1

Exclusivity Details :

blank

03

arrow
BioFlorida Conference
Not Confirmed

HOFFMANN-LA ROCHE

Switzerland
arrow
BioFlorida Conference
Not Confirmed

ALECTINIB HYDROCHLORIDE

Exclusivity Code : ODE-477

Exclusivity Expiration Date : 2031-04-18

Application Number : 208434

Product Number : 1

Exclusivity Details :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty